Special Issue "Coronary Artery Disease Interventions"
- PMID: 38337511
- PMCID: PMC10856644
- DOI: 10.3390/jcm13030817
Special Issue "Coronary Artery Disease Interventions"
Abstract
The treatment and burden of patients with severe ischemic heart disease, whether acute or chronic, remain some of the greatest challenges in cardiology [...].
Conflict of interest statement
D.v.L. is on the advisory board and the speakers’ bureau of Abiomed, AstraZeneca, Bayer, Daiichi Sankyo, Orion, Sanofi, and Servier, and receives consulting fees from Recardio Inc., Bayer, TLL, Vaxxinity Inc. G.G.T. receives unrestricted research support and/or consultancy fees from Abbott, Abiomed, Biotronik, Boston Scientific, Chiesi, Cordis, Medtronic, and Terumo. L.H. declares no conflict of interest.
References
-
- Kodeboina M., Piayda K., Jenniskens I., Vyas P., Chen S., Pesigan R.J., Ferko N., Patel B.P., Dobrin A., Habib J., et al. Challenges and Burdens in the Coronary Artery Disease Care Pathway for Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Narrative Review. Int. J. Environ. Res. Public Health. 2023;20:5633. doi: 10.3390/ijerph20095633. - DOI - PMC - PubMed
-
- Chiarito M., Cao D., Nicolas J., Roumeliotis A., Power D., Chandiramani R., Sartori S., Camaj A., Goel R., Claessen B.E., et al. Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials. Catheter. Cardiovasc. Interv. 2021;97:1387–1396. doi: 10.1002/ccd.29486. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
